Stacy Burch

Stacy Burch is an experienced marketing executive with a strong background in the biotech and pharmaceutical industries. Currently serving as Vice President of Marketing at Cristcot since August 2025, Stacy leads commercialization and brand strategy for a novel ulcerative colitis drug therapy and device. Previous roles include Vice President of North America Marketing at embecta, where Stacy managed a $600M+ business and executed brand transition strategies, and Vice President of Marketing and Commercial Excellence at BD, overseeing a $592 million Diabetes Care segment. Additional experience spans leadership positions in marketing strategy at Eisai US, AstraZeneca, and Sanofi, where Stacy contributed to significant product launches and operational excellence across diverse therapeutic areas. Educational credentials include MBA courses at MIT Sloan School of Management and Kellogg School of Management.